The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia

Bezmialem Vakif University200 enrolled

Overview

The aim of our study is to evaluate the effectiveness of proton pump inhibitor (PPI) treatment in patients with functional dyspepsia.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

200

Conditions

Nonulcer Dyspepsia

Interventions

PantoprazolDRUG

40mg/day, oral, 28 days

Folic AcidDRUG

5 mg/day, oral, 28 days

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * aged 18-45 years with symptoms of dyspepsia, * no evidence of organic disease. Exclusion Criteria: * Patients with alarm symptoms, * Severe concomitant illness, * Pregnancy or lactation, * Alcohol or drug abuse, * Use of aspirin or other non-steroidal anti-inflammatory drugs antibiotics, H2 receptor blockers, bismuth, or proton pump inhibitors in the preceding two weeks

Locations (1)

Bezmialem medical faculty

Istanbul, Turkey (Türkiye)

Outcomes

Primary Outcomes

Effectiveness of pantoprazole treatment in patients with functional dyspepsia measured by symptoms scale.

Time frame: one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.